Baxter/BMS/3M breast implant settlement needs board approval by Nov. 13.
This article was originally published in The Gray Sheet
Executive Summary
BAXTER/BRISTOL-MEYERS SQUIBB/3M BREAST IMPLANT SETTLEMENT would provide $10,000-600,000 in compensation on a per-patient basis, substantially less than the amount promised under the original "global" class action settlement. Judge Samuel Pointer of the U.S. District Court of Alabama approved the agreement on Oct. 7, signing off on a deal that would cover only recipients of Baxter, Bristol-Myers Squibb and 3M implants.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.